Biotechnology Industry Stocks & Companies | Europe

The Biotechnology Industry includes 54 publicly traded companies in the Europe market.

Together these companies represent a combined market capitalization of €124.57 Billion with an average price-to-earnings ratio of 36.4.

The largest companies in this industry are ARGX.BR (ARGENX SE) and 22UA.DE (BIONTECH SE-ADR). Together they account for 45.04% of the total market capitalization of the industry.

Below you can explore the complete list of Biotechnology Industry, including market capitalization, revenue, valuation ratios, dividend yield, and performance statistics.

Largest Companies in the Biotechnology Industry

The following companies currently represent the largest weights in the Biotechnology Industry.

1. ARGENX SE (ARGX.BR)
2. ARGENX SE (1AE.DE)
3. BIONTECH SE-ADR (22UA.DE)
4. ABIVAX SA (ABVX.PA)
5. ABIVAX SA (2X1.DE)
6. GALAPAGOS NV (GXE.DE)
7. GALAPAGOS NV (GLPG.AS)
8. NANOBIOTIX (NANO.PA)
9. INVENTIVA SA (IVA.PA)
10. INVENTIVA SA (6IV.DE)

Biotechnology Industry Statistics

The Biotechnology Industry has on average fallen 10.4% over the last 3 months. These averages are based on an weighted average of 54 stocks in this industry.

Total Market Cap
124.57B
Total Revenue
15.65B
Total Net Income
468.17M
Avg Price/Earnings (W)
36.4
Avg Debt/Equity (W)
0
Avg ROE (W)
20.7
Avg Relative Strength
43.2
Avg Perf Today (W)
2%
Best Perf Today
61.6%
Worst Perf Today
-13%
% Winners Today
38.9%
New Highs (Last Week)
3.7%
New Lows (Last Week)
14.8%
Avg 1 Week Perf (W)
-2%
Avg 2 Week Perf (W)
-9.2%
Avg 1 Month Perf (W)
-7.7%
Avg 3 Month Perf (W)
-10.4%
Avg 1 Year Perf (W)
127.1%
Avg 3 Year Perf (W)
119.3%
See full Biotechnology Industry Statistics

All Biotechnology Industry Stocks

The full list of Biotechnology Industry stocks, sorted by Market Cap and weight inside the industry. Zoom in on the Technicals or Fundamentals or open the list in the screener for additional metrics, charts and export.



SymbolCompanyMarket CapWeightTA RatingFA RatingDiv %% Chg3M %1Y %PEAnalysts
ARGX.BRARGENX SE39.56B31.75%0 / 106 / 10N/A-1.44%-15.14%16.01%37.5784.00
1AE.DEARGENX SE39.49B31.70%1 / 106 / 10N/A1.27%-15.18%N/A38.0684.00
22UA.DEBIONTECH SE-ADR16.56B13.29%1 / 103 / 10N/A13.76%-15.05%-24.05%N/A81.43
ABVX.PAABIVAX SA7.85B6.30%3 / 101 / 10N/A-2.62%-8.23%1718.68%N/A85.71
2X1.DEABIVAX SA7.84B6.30%3 / 101 / 10N/A5.20%-7.98%N/AN/A85.71
GXE.DEGALAPAGOS NV1.90B1.52%4 / 105 / 10N/A2.05%6.19%N/A5.9252.22
GLPG.ASGALAPAGOS NV1.90B1.52%6 / 105 / 10N/A-2.85%5.88%20.40%5.7552.22
NANO.PANANOBIOTIX1.59B1.28%10 / 101 / 10N/A-10.50%68.81%1014.31%N/A85.00
IVA.PAINVENTIVA SA1.17B0.94%10 / 102 / 10N/A-1.41%51.06%109.21%N/A88.00
6IV.DEINVENTIVA SA1.11B0.89%4 / 102 / 10N/A0.00%N/AN/AN/A88.00
PHIL.MIPHILOGEN SPA669.60M0.54%4 / 107 / 10N/A-0.87%-1.72%22.13%19.9180.00
GNFT.PAGENFIT468.03M0.38%10 / 102 / 10N/A-4.59%83.53%181.93%N/A90.00
VLA.PAVALNEVA SE427.12M0.34%10 / 102 / 10N/A-3.45%32.06%56.38%N/A81.82
AYJ.DEVALNEVA SE425.39M0.34%10 / 102 / 10N/A6.10%32.17%55.25%N/A81.82
XUP.DEGENFIT425.02M0.34%3 / 102 / 10N/A61.60%N/AN/AN/A90.00
FYB.DEFORMYCON AG356.93M0.29%0 / 103 / 10N/A-3.17%-15.13%-26.81%N/A83.08
ALCLS.PACELLECTIS346.62M0.28%5 / 102 / 10N/A5.98%-15.94%182.27%N/A84.62
ALSEN.PASENSORION SA242.54M0.19%8 / 103 / 10N/A12.68%39.76%-16.19%N/A87.14
ALERS.PAEUROBIO-SCIENTIFIC232.68M0.19%0 / 106 / 10N/A0.89%-6.20%-10.45%98.7084.44
DBV.DEDBV TECHNOLOGIES SA220.66M0.18%4 / 102 / 10N/A1.01%64.89%N/AN/A80.00
DBV.PADBV TECHNOLOGIES SA220.11M0.18%10 / 102 / 10N/A-4.24%24.38%355.11%N/A80.00
TNG.PATRANSGENE SA219.90M0.18%0 / 101 / 10N/A-0.75%-15.76%16.06%N/A82.86
HPHA.DEHEIDELBERG PHARMA AG142.68M0.11%6 / 102 / 10N/A-0.33%8.54%17.31%N/A82.50
MAAT.PAMAAT PHARMA SACA137.39M0.11%8 / 102 / 10N/A-1.92%72.17%22.90%N/A87.27
IPH.PAINNATE PHARMA SA131.38M0.11%0 / 102 / 10N/A-2.14%-14.09%-25.11%N/A82.50
ADOC.PAADOCIA SAS126.68M0.10%3 / 102 / 10N/A-4.64%-7.71%46.49%N/A84.44
ABNX.PAABIONYX PHARMA SA122.33M0.10%3 / 102 / 10N/A-2.47%-1.71%180.08%N/A85.00
PHGN.DEPHARMING GROUP NV97.40M0.08%4 / 105 / 10N/A2.72%3.79%N/AN/A88.57
PHARM.ASPHARMING GROUP NV96.91M0.08%6 / 105 / 10N/A-1.37%-5.05%76.97%N/A88.57
OSE.PAOSE IMMUNO91.28M0.07%0 / 102 / 10N/A-2.21%-18.23%-36.00%N/A80.00
ALVIO.PAVALERIO TX70.67M0.06%5 / 100 / 10N/A3.66%-1.05%174.22%N/A34.29
VVY.ASVIVORYON THERAPEUTICS NV40.21M0.03%0 / 102 / 10N/A-1.45%-10.66%-28.07%N/A85.71
ALCOX.PANICOX SA39.80M0.03%10 / 103 / 10N/A2.51%53.58%66.67%N/A84.44
ALGEN.PAGENOWAY SA29.84M0.02%0 / 104 / 10N/A0.00%-4.47%-32.86%15.6786.67
ALNOV.PANOVACYT27.19M0.02%0 / 102 / 10N/A-0.13%-10.67%-34.86%N/A37.14
ALVAL.PAVALBIOTIS SA24.84M0.02%7 / 102 / 10N/A5.86%51.01%-2.06%N/A85.45
SIGHT.PAGENSIGHT BIOLOGICS SA22.49M0.02%4 / 101 / 10N/A-7.66%12.61%-59.20%N/A80.00
ALEMS.BREUROPEAN MEDICAL SOLUTIONS S20.94M0.02%1 / 102 / 10N/A0.01%-9.99%-22.53%18.3434.29
ARBS.MIARTERRA BIOSCIENCE SPA18.12M0.01%3 / 107 / 104.78%-7.48%15.25%N/A9.0782.86
AELIS.PAAELIS FARMA SAS16.59M0.01%2 / 102 / 10N/A5.68%9.50%0.00%N/A84.44
POXEL.PAPOXEL SA13.90M0.01%3 / 101 / 10N/A-4.45%-1.15%36.05%N/A84.44
ALNFL.PANFL BIOSCIENCES SA13.58M0.01%0 / 102 / 10N/A1.71%-2.01%-36.87%N/A81.82
ALPRE.PAPREDILIFE SA12.46M0.01%0 / 102 / 10N/A0.96%-0.94%-15.69%N/A86.67
ALOPM.PAONCODESIGN PRECISION MEDICIN11.06M0.01%10 / 102 / 10N/A2.75%49.50%73.33%N/A84.44
ALPAT.PAPLANT ADVANCED TECHNOLOGIES7.96M0.01%0 / 103 / 10N/A-1.95%-16.59%-34.21%25.1484.44
CYAD.BRCELYAD ONCOLOGY7.23M0.01%7 / 101 / 10N/A-5.33%72.97%-43.86%N/A42.22
ALTME.PATME PHARMA NV7.19M0.01%4 / 100 / 10N/A2.83%24.06%7.46%N/A84.44
ALTAO.PAATON SA4.97M0.00%0 / 101 / 10N/A0.00%-14.29%-36.84%N/A34.29
BIOS.BRBIOSENIC SA1.50M0.00%2 / 100 / 10N/A-13.04%4.55%-8.00%N/A42.22
ALINT.PAINTEGRAGEN1.20M0.00%5 / 102 / 10N/A0.00%27.50%-66.64%N/A86.67
ALBPS.PABIOPHYTIS514.56K0.00%0 / 100 / 10N/A-1.32%-43.95%-86.19%N/A84.44
OXUR.BROXURION NV406.58K0.00%0 / 102 / 10N/A3.45%-32.56%-96.48%0.0142.22
ALNEV.PANEOVACS576.000.00%0 / 102 / 10N/A0.00%-88.12%-100.00%N/A86.67
7V0.DEDARWIN AGN/A0.00%2 / 100 / 106.90%-1.19%9.21%-68.32%N/A83.33

About the Biotechnology Industry

Companies primarily engaged in the research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering. Includes companies specializing in protein-based therapeutics to treat human diseases. Excludes companies manufacturing products using biotechnology but without a health care application.



Last updated: Wednesday, March 11, 2026